AIRS Medical Gets FDA Clearance for MRI Body Composition Tool

Oct 6, 2026
The FDA cleared SwiftSight Body Composition, an AI system that measures muscle, fat distribution, muscle balance, and liver fat from MRI scans.

AIRS Medical said in a press release that the FDA granted 510(k) clearance for SwiftSight Body Composition on October 5. The AI software measures muscle, visceral and subcutaneous fat, muscle quality, muscle balance, and liver fat from MRI images.

The scan takes less than five minutes, followed by automated analysis and segmentation. The software compares measurements with reference populations matched by age and sex, then produces a report with measurements, percentile rankings, and visual summaries.

The system also evaluates abdominal and thigh muscles, including the psoas, quadriceps, hamstrings, and adductors. SimonMed Imaging will be the first customer to deploy the product.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.